Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Buy
7,074
+696
+11% +$128K 0.01% 651
2025
Q4
$1.12M Buy
6,378
+21
+0.3% +$3.43K 0.01% 645
2025
Q3
$890K Buy
6,357
+121
+2% +$16.4K 0.01% 692
2025
Q2
$783K Sell
6,236
-727
-10% -$90.6K ﹤0.01% 709
2025
Q1
$953K Sell
6,963
-122
-2% -$17.4K 0.01% 641
2024
Q4
$1.08M Sell
7,085
-2,830
-29% -$477K 0.01% 611
2024
Q3
$1.92M Buy
9,915
+1,014
+11% +$212K 0.01% 484
2024
Q2
$2.06M Sell
8,901
-320
-3% -$69.5K 0.01% 466
2024
Q1
$1.99M Buy
9,221
+59
+0.6% +$13.8K 0.01% 473
2023
Q4
$2.37M Sell
9,162
-75
-0.8% -$18.4K 0.02% 442
2023
Q3
$2.37M Sell
9,237
-163
-2% -$43.6K 0.02% 426
2023
Q2
$2.68M Buy
9,400
+118
+1% +$35.1K 0.02% 407
2023
Q1
$2.58M Sell
9,282
-149
-2% -$41.2K 0.02% 399
2022
Q4
$2.61M Buy
9,431
+10
+0.1% +$2.82K 0.02% 397
2022
Q3
$2.52M Buy
9,421
+160
+2% +$34K 0.02% 399
2022
Q2
$1.89M Buy
9,261
+386
+4% +$78.9K 0.02% 447
2022
Q1
$1.87M Sell
8,875
-2,198
-20% -$478K 0.01% 472
2021
Q4
$2.66M Buy
11,073
+209
+2% +$53.7K 0.02% 424
2021
Q3
$3.07M Buy
10,864
+1,445
+15% +$474K 0.02% 402
2021
Q2
$3.26M Sell
9,419
-19,584
-68% -$5.93M 0.02% 389
2021
Q1
$8.11M Sell
29,003
-1,563
-5% -$422K 0.06% 227
2020
Q4
$7.49M Sell
30,566
-440
-1% -$114K 0.06% 224
2020
Q3
$8.8M Sell
31,006
-564
-2% -$157K 0.08% 197
2020
Q2
$8.45M Buy
31,570
+1,571
+5% +$472K 0.08% 180
2020
Q1
$9.49M Buy
29,999
+677
+2% +$205K 0.11% 139
2019
Q4
$8.7M Buy
29,322
+588
+2% +$163K 0.08% 176
2019
Q3
$6.69M Sell
28,734
-358
-1% -$83.4K 0.07% 204
2019
Q2
$6.8M Sell
29,092
-485
-2% -$112K 0.08% 170
2019
Q1
$6.99M Sell
29,577
-405
-1% -$128K 0.08% 163
2018
Q4
$9.02M Buy
29,982
+832
+3% +$266K 0.11% 137
2018
Q3
$10.3M Buy
29,150
+202
+0.7% +$69.5K 0.12% 138
2018
Q2
$8.4M Buy
28,948
+485
+2% +$136K 0.11% 148
2018
Q1
$7.79M Sell
28,463
-362
-1% -$112K 0.1% 153
2017
Q4
$9.18M Buy
28,825
+150
+0.5% +$48.1K 0.12% 142
2017
Q3
$8.98M Buy
28,675
+250
+0.9% +$74K 0.12% 142
2017
Q2
$7.71M Sell
28,425
-79
-0.3% -$20.9K 0.11% 144
2017
Q1
$7.79M Buy
28,504
+682
+2% +$193K 0.11% 144
2016
Q4
$7.89M Sell
27,822
-463
-2% -$137K 0.12% 142
2016
Q3
$8.85M Buy
28,285
+610
+2% +$181K 0.14% 137
2016
Q2
$6.69M Sell
27,675
-37
-0.1% -$9.75K 0.11% 152
2016
Q1
$7.21M Sell
27,712
-1,395
-5% -$368K 0.12% 148
2015
Q4
$8.92M Buy
29,107
+161
+0.6% +$46.3K 0.15% 132
2015
Q3
$8.45M Sell
28,946
-2,034
-7% -$672K 0.15% 137
2015
Q2
$12.5M Buy
30,980
+40
+0.1% +$16.1K 0.2% 121
2015
Q1
$13.1M Sell
30,940
-6
-0% -$2.37K 0.2% 113
2014
Q4
$10.5M Buy
30,946
+68
+0.2% +$22K 0.17% 131
2014
Q3
$10.2M Buy
30,878
+545
+2% +$180K 0.17% 127
2014
Q2
$9.56M Buy
30,333
+69
+0.2% +$20.8K 0.16% 130
2014
Q1
$9.26M Sell
30,264
-52
-0.2% -$16.5K 0.16% 127
2013
Q4
$8.47M Sell
30,316
-2,603
-8% -$673K 0.15% 129
2013
Q3
$7.93M Sell
32,919
-309
-0.9% -$69.2K 0.14% 130
2013
Q2
$7.15M Buy
+33,228
New +$7.1M 0.13% 139

Other funds holding BIIB

Commerce Bank's BIIB Position: Q1 2026 in Review

Commerce Bank increased its Biogen (BIIB) stake by 11% in Q1 2026, buying an estimated $128K and bringing the position to 7,074 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #651.

Commerce Bank first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.1M in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Commerce Bank held 7,074 shares of Biogen worth $1.3M as of Q1 2026.
  • Commerce Bank bought 696 Biogen shares in Q1 2026, an estimated $128K.
  • Biogen made up 0.01% of Commerce Bank's portfolio in Q1 2026, its #651 holding.
  • Commerce Bank first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • Commerce Bank's Biogen position peaked at $13.1M in Q1 2015.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Commerce Bank's 13F filing for Q1 2026, filed 11 May 2026.